1-Bromo-2-((4-bromobenzyl)oxy)-3,4-difluorobenzene
- CAS No.
- 2586127-01-5
- Chemical Name:
- 1-Bromo-2-((4-bromobenzyl)oxy)-3,4-difluorobenzene
- Synonyms
- 1-Bromo-2-((4-bromobenzyl)oxy)-3,4-difluorobenzene;Benzene, 1-bromo-2-[(4-bromophenyl)methoxy]-3,4-difluoro-
- CBNumber:
- CB88548751
- Molecular Formula:
- C13H8Br2F2O
- Molecular Weight:
- 378.01
- MDL Number:
- MFCD32902824
- MOL File:
- 2586127-01-5.mol
- MSDS File:
- SDS
Last updated:2026-05-28 03:35:12
SAFETY
Risk and Safety Statements
| Symbol(GHS) | ![]() GHS07 |
|---|---|
| Signal word | Warning |
| Hazard statements | H302-H315-H319-H335 |
| Precautionary statements | P280-P305+P351+P338 |
1-Bromo-2-((4-bromobenzyl)oxy)-3,4-difluorobenzene price
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| aablocks | AA021P4K | 1-Bromo-2-((4-bromobenzyl)oxy)-3,4-difluorobenzene 97% | 2586127-01-5 | 1g | $212 | 2026-06-01 | Buy |
| ACHEMBLOCK | X175062 | 1-Bromo-2-((4-bromobenzyl)oxy)-3,4-difluorobenzene 95% | 2586127-01-5 | 1G | $240 | 2026-05-27 | Buy |
| ACHEMBLOCK | X175062 | 1-Bromo-2-((4-bromobenzyl)oxy)-3,4-difluorobenzene 95% | 2586127-01-5 | 5G | $870 | 2026-05-27 | Buy |
1-Bromo-2-((4-bromobenzyl)oxy)-3,4-difluorobenzene Preparation Products And Raw materials
Raw materials
Preparation Products
1-Bromo-2-((4-bromobenzyl)oxy)-3,4-difluorobenzene Suppliers
Global Suppliers ( 2)
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| AAB-PHARMA LIMITED | 02566880956 | 3325708371@qq.com | China | 7868 | 58 |
| Zhuhai Aobokai Biomedical Technology Co., Ltd. | 400-0628126 | sales-team@aobchem.com.cn | China | 49939 | 58 |
| Supplier | Advantage |
|---|---|
| AAB-PHARMA LIMITED | 58 |
| Zhuhai Aobokai Biomedical Technology Co., Ltd. | 58 |
2586127-01-5 (1-Bromo-2-((4-bromobenzyl)oxy)-3,4-difluorobenzene) Related Search:
1-Bromo-2-((4-bromobenzyl)oxy)-3,4-difluorobenzene
Benzene, 1-bromo-2-[(4-bromophenyl)methoxy]-3,4-difluoro-
2586127-01-5





